Australian public health advocates seek access to regional trade pact negotiations

The prime lobby group for American pharmaceutical manufacturers has been given privileged access to negotiations for a major regional trade pact that could see the cost of medicines skyrocket in Australia, reports the Sydney Morning Herald. Public health advocates and business groups are concerned that pharmaceutical giants will be able to advance their commercial interests while the details of the pact are kept secret from the Australian public.